Literature DB >> 22175887

Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours.

Maria A Pantaleo1, Annalisa Astolfi, Margherita Nannini, Claudio Ceccarelli, Serena Formica, Donatella Santini, Michael C Heinrich, Christopher Corless, Angelo Paolo Dei Tos, Paola Paterini, Fausto Catena, Alessandra Maleddu, Maristella Saponara, Monica Di Battista, Guido Biasco.   

Abstract

AIMS: To compare the genomic signatures of wild-type (WT) and mutated GISTs and the murine interstitial cells of Cajal (ICCs) to find markers of cell differentiation and other functions that may identify cells that give rise to WT tumours. METHODS AND
RESULTS: We analysed the gene expression profiles of a total of 30 tumour samples (four WT GISTs and 26 mutated GISTs), selected the genes most differentially expressed (P < 0.001:448 probe sets) and validated these results by quantitative polymerase chain reaction (PCR) and immunohistochemistry. In addition, we conducted a meta-analysis merging data from human GISTs with a genomic data set from murine ICCs. The gene expression profiles of WT and mutated GISTs differed profoundly, especially in the expression of those genes restricted primarily to neural tissues. We found that mature ICCs are more similar to mutated GISTs than WT GISTs.
CONCLUSIONS: WT GISTs have different genomic profiles from both mutated GISTs and murine mature ICCs. Considering that IGF1R expression is common to both WT GISTs and putative precursor ICCs, this study suggests that WT GISTs may derive either from ICCs at a different step of differentiation or from a different cell of origin.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175887     DOI: 10.1111/j.1365-2559.2011.04071.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Role of molecular analysis in the adjuvant treatment of gastrointestinal stromal tumours: it is time to define it.

Authors:  Margherita Nannini; Maria A Pantaleo; Guido Biasco
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

2.  Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Douglas B Flieder; Mona S Jahromi; Joshua D Schiffman; Andrew K Godwin; Margaret von Mehren
Journal:  Genes Chromosomes Cancer       Date:  2012-10-29       Impact factor: 5.006

3.  Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Margaret von Mehren
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

4.  Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.

Authors:  Carol Beadling; Janice Patterson; Emily Justusson; Dylan Nelson; Maria A Pantaleo; Jason L Hornick; Matias Chacón; Christopher L Corless; Michael C Heinrich
Journal:  Cancer Med       Date:  2013-02-03       Impact factor: 4.452

5.  Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

Authors:  Margherita Nannini; Annalisa Astolfi; Milena Urbini; Valentina Indio; Donatella Santini; Michael C Heinrich; Christopher L Corless; Claudio Ceccarelli; Maristella Saponara; Anna Mandrioli; Cristian Lolli; Giorgio Ercolani; Giovanni Brandi; Guido Biasco; Maria A Pantaleo
Journal:  BMC Cancer       Date:  2014-09-20       Impact factor: 4.430

6.  The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).

Authors:  Margherita Nannini; Milena Urbini; Annalisa Astolfi; Guido Biasco; Maria A Pantaleo
Journal:  J Transl Med       Date:  2017-05-23       Impact factor: 5.531

7.  miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.

Authors:  Yu Wang; Jun Li; Dong Kuang; Xiaoyan Wang; Yuanli Zhu; Sanpeng Xu; Yaobing Chen; Henghui Cheng; Qiu Zhao; Yaqi Duan; Guoping Wang
Journal:  Cell Commun Signal       Date:  2018-04-16       Impact factor: 5.712

8.  SDHC methylation in gastrointestinal stromal tumors (GIST): a case report.

Authors:  Milena Urbini; Annalisa Astolfi; Valentina Indio; Michael C Heinrich; Christopher L Corless; Margherita Nannini; Gloria Ravegnini; Guido Biasco; Maria A Pantaleo
Journal:  BMC Med Genet       Date:  2015-09-28       Impact factor: 2.103

Review 9.  The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor.

Authors:  Annalisa Astolfi; Maria Abbondanza Pantaleo; Valentina Indio; Milena Urbini; Margherita Nannini
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.